共 50 条
Triple Negative Breast Cancer
被引:36
|作者:
Cetin, Idil
[1
]
Topcul, Mehmet
[2
]
机构:
[1] Istanbul Univ, Fac Sci, Dept Radiobiol, Istanbul, Turkey
[2] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey
关键词:
Triple negative breast cancer;
poor prognosis;
targeted therapy;
ENDOTHELIAL GROWTH-FACTOR;
FACTOR RECEPTOR;
MOLECULAR SUBTYPES;
RISK-FACTORS;
STEM-CELLS;
PROGNOSTIC VALUE;
BASAL;
CHEMOTHERAPY;
CARCINOMA;
SURVIVAL;
D O I:
10.7314/APJCP.2014.15.6.2427
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Triple-negative breast cancers (TNBC), characterized by absence of the estrogen receptor (ER) and progesterone receptor (PR) and lack of overexpression of human epidermal growth factor receptor 2 (HER2), have a poor prognosis. To overcome therapy limitations of TNBC, various new approaches are needed. This mini-review focuses on discovery of new targets and drugs which might offer new hope for TNBC patients.
引用
收藏
页码:2427 / 2431
页数:5
相关论文